Abstract
Biofilm is an aggregation of microorganisms adhered to the substrate and confined in an extracellular polymeric substance (EPS). The property of enhanced resistance to host immune response and antibiotics confer them a unique advantage over planktonic cells. Biofilm plays a vital role in microbial pathogenesis, medical device-associated infection and equipment damage. Microbial biofilm presents a critical medical challenge as a result of they are recalcitrant to current therapeutic regimes. One of the distinctive features of bacterial biofilms is an enhanced resistance and tolerance to antibiotics. Compared to the planktonic community, bacterial cells inside the biofilms have proven to be a thousand times more tolerant to standard antibiotics and are resistant to the natural defence mechanism by the host, making them highly difficult to remove. Some of the current biofilm mitigation approaches use biofilm inhibitors to prevent biofilm formation or agents that can disperse preformed biofilm. This review paper summarises the current methods employed to inhibit bacterial biofilm and agents that eradicate biofilms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asia Pacific Journal of Molecular Biology and Biotechnology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
